Prof. Toh Han Chong
Organization: National Cancer Centre Singapore
Project Name: ASCOLT STUDY (phase III): Aspirin as an Adjuvant Therapy for Colorectal Cancer
Funding Year: 2016
Project period: 5 years
ASCOLT STUDY (phase III): Aspirin as an Adjuvant Therapy for Colorectal Cancer
This phase III trial will assess the effectiveness of daily aspirin against placebo control in stage 2 and 3 patients. This is an international collaboration led by researchers in Singapore, UK, and Australia, and involves 50 sites in 11 countries across Asia.